SCHEMBL2741575

SCHEMBL2741575

Cc1ccc(-c2ccc(Br)c(F)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.44
▸ PTGS2 P35354 2/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ ACHE P22303 2/20 0.39
▸ IDO1 P14902 1/20 0.38
▸ AR P10275 1/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ RPS6KA3 P51812 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ KDM1A O60341 2/20 0.36
▸ KCNH2 Q12809 2/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ KDM1B Q8NB78 1/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ NFE2L2 Q16236 2/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299673 0.86 KIF11 (0.55) KIF11IDO1CYP1A2KDM1AKCNH2
SCHEMBL257619 0.82 KIF11 (0.49) KIF11ALDH1A1PTGS2PTGS1IDO1
SCHEMBL12384880 0.82 RAB9A (0.44) KIF11ALDH1A1ACHEIDO1AR
SCHEMBL29570973 0.81 — —
SCHEMBL157146 0.81 — —
SCHEMBL1042606 0.80 ALDH1A1 (0.54) KIF11ALDH1A1IDO1MAPTCYP11B1
SCHEMBL30285974 0.80 ALDH1A1 (0.54) KIF11ALDH1A1IDO1MAPTCYP11B1
SCHEMBL265481 0.79 NFE2L2 (0.54) PTGS2PTGS1ACHEARCYP1A2
SCHEMBL12011026 0.79 NFE2L2 (0.54) PTGS2PTGS1ACHEARCYP1A2
SCHEMBL16258105 0.79 NFE2L2 (0.54) PTGS2PTGS1ACHEARCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150323722-A1 REACTIVE MESOGENS MERCK PATENT GMBH (DE) 2015-11-12 — — US disclosed
US-8486297-B2 Thiophene derivatives, and LC media comprising same MERCK PATENT GMBH (DE) 2013-07-16 — — US disclosed
US-8394293-B2 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-03-12 — — US disclosed
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-05 — — US disclosed
US-20110049427-A1 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME TEC, TPMT, TST KIF11 1267/4885ALDH1A1 3650/4885PTGS2 2798/4885
US-20150323722-A1 REACTIVE MESOGENS BLM, MAFG, MCRS1 KIF11 811/4885ALDH1A1 4654/4885PTGS2 1889/4885
US-20110049427-A1 Thiophene derivatives, and LC media containing same TPMT, TEC, LCT KIF11 1344/4885ALDH1A1 3692/4885PTGS2 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback